↓ Skip to main content

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with…

Overview of attention for article published in BMC Cancer, March 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
reddit
1 Redditor

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
43 Mendeley